Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish American Tobacco Regulatory News (BATS)

Share Price Information for British American Tobacco (BATS)

Share Price is delayed by 15 minutes
Get Live Data
4,404.00    84.00 (1.94%)
Bid:
4,423.00
Ask:
4,425.00
Spread: 2.00 (0.045%)
Market Cap: £95.19b
BATS Live PriceLast checked at - London Stock Exchange

Intraday British American Tobacco Share Chart

Share Buyback Programme

10 Dec 2025 07:00

RNS Number : 8904K
British American Tobacco PLC
10 December 2025
 

British American Tobacco p.l.c. (the "Company")

 

10 December 2025

 

Extension of Share Buyback Programme

 

Further to its announcement on 9 December 2025 in its trading update, the Company announces the extension of its share buyback programme, originally announced on 18 March 2024, by up to £1.3 billion for 2026 ("the Programme").

 

The Company has entered into an irrevocable, non-discretionary agreement with UBS AG London Branch ("UBS") to purchase ordinary shares of the Company ("Shares") for the next tranche of the Programme, which is expected to be completed during the Company's closed period commencing on 2 January 2026 and ending at the close of business on 11 February 2026, the day prior to the release of its full year preliminary results. 

 

UBS will make its trading decisions in relation to the Company's Shares independently of, and uninfluenced by, the Company.

The purpose of the Programme is to reduce the share capital of the Company. The Shares repurchased will be cancelled. The maximum number of Shares permitted to be purchased by the Company under the Programme, pursuant to the authority granted by its shareholders at the Company's 2025 AGM, is 220,451,469 Shares (less the number of Shares subsequently purchased by the Company under the Programme since that authority was granted).

Any purchases of Shares by the Company in relation to this announcement will be undertaken within certain pre-set parameters, and in accordance with both the Company's general authority to repurchase shares granted by its shareholders at the Company's 2025 AGM (the "Authority"), the Market Abuse Regulation 596/2014 and the Commission Delegated Regulation (2016/1052), in each case as such legislation forms part of domestic law by virtue of section 3 of the European Union (Withdrawal) Act 2018 (as amended), and Chapter 9.6 of the Financial Conduct Authority's UK Listing Rules.

Pursuant to the Authority, the maximum price which may be paid for a Share is an amount (exclusive of taxes and expenses) equal to the higher of:

- 105 per cent of the average market value of a Share as derived from the LSE's Daily Official List for the five business days immediately preceding the day on which the Share is purchased, in accordance with Listing Rule 9.6.1 of the Listing Rules published pursuant to Part 6 of the Financial Services and Markets Act 2000 ("FSMA") (the "Listing Rules"); and

- the higher of (i) the price of the last independent trade and (ii) the highest current independent purchase bid on the trading venue where the purchase is carried out, including when the shares are traded on different trading venues, in accordance with Article 3(2) of the UK Safe Harbour Regulation.

Enquiries:

 

Investor Relations 

Victoria Buxton: | IR_team@bat.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFSIFMUEISEFE
Date   Source Headline
24th Jun 20247:00 amRNSClosed Period Share Repurchase Programme
21st Jun 20247:00 amRNSTransaction in Own Shares
20th Jun 202411:05 amRNSDirector/PDMR Shareholding
20th Jun 202411:00 amRNSDirector/PDMR Shareholding
20th Jun 20247:00 amRNSTransaction in Own Shares
19th Jun 20247:00 amRNSTransaction in Own Shares
18th Jun 20247:05 amRNSTransaction in Own Shares
18th Jun 20247:00 amRNSBranch Register: Dividend Finalisation Information
17th Jun 20247:00 amRNSTransaction in Own Shares
14th Jun 20247:00 amRNSTransaction in Own Shares
13th Jun 20247:00 amRNSTransaction in Own Shares
12th Jun 20243:35 pmRNSDirector/PDMR Shareholding
12th Jun 20247:00 amRNSTransaction in Own Shares
11th Jun 20247:00 amRNSTransaction in Own Shares
10th Jun 20247:00 amRNSTransaction in Own Shares
7th Jun 20247:00 amRNSTransaction in Own Shares
6th Jun 202412:00 pmRNSDirector/PDMR Shareholding
6th Jun 20247:00 amRNSTransaction in Own Shares
5th Jun 20244:45 pmRNSDirector/PDMR Shareholding
4th Jun 20247:05 amRNSTransaction in Own Shares
4th Jun 20247:00 amRNSTrading Statement
3rd Jun 202411:20 amRNSTotal Voting Rights
3rd Jun 20247:00 amRNSTransaction in Own Shares
31st May 20247:00 amRNSTransaction in Own Shares
30th May 20247:00 amRNSTransaction in Own Shares
29th May 20247:00 amRNSTransaction in Own Shares
28th May 20247:00 amRNSTransaction in Own Shares
24th May 20247:00 amRNSTransaction in Own Shares
23rd May 20247:00 amRNSTransaction in Own Shares
22nd May 20247:00 amRNSTransaction in Own Shares
21st May 20247:00 amRNSTransaction in Own Shares
20th May 20247:00 amRNSTransaction in Own Shares
17th May 20247:00 amRNSTransaction in Own Shares
16th May 20247:00 amRNSTransaction in Own Shares
15th May 20247:00 amRNSTransaction in Own Shares
14th May 20247:00 amRNSTransaction in Own Shares
13th May 202410:15 amRNSDirector/PDMR Shareholding
13th May 20247:00 amRNSTransaction in Own Shares
10th May 202411:05 amRNSDirector/PDMR Shareholding
10th May 202410:40 amRNSDirector/PDMR Shareholding
10th May 20247:00 amRNSTransaction in Own Shares
9th May 20245:48 pmRNSDirector Declaration
9th May 202410:35 amRNSDirector/PDMR Shareholding
9th May 202410:30 amRNSDirector/PDMR Shareholding
8th May 202410:40 amRNSDirector/PDMR Shareholding
8th May 202410:35 amRNSDirector/PDMR Shareholding
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20241:05 pmRNSDirector/PDMR Shareholding
7th May 20241:00 pmRNSDirector/PDMR Shareholding
7th May 202411:20 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.